推荐应用
Tumor Necrosis Factor Receptor II (TNF RII), also known as TNFRSF1B, p75/p80, and CD120b, is a type I transmembrane protein that belongs to the TNF receptor superfamily. It has a molecular weight of approximately 75 kDa. Human TNF RII contains four cysteine-rich repeats in its ECD, which shares 58% and 56% amino acid sequence identity with the mouse and rat orthologs, respectively. Those receptors that lack DDs, like TNF RII, bind TNF Receptor-associated Factors, which transduce signals generated by activation of these receptors. Polymorphisms of the human TNFR2 gene, which result in increased expression of both membrane-bound and soluble TNF RII, have been associated with several autoimmune diseases including Crohn’s disease, systemic lupus erythematosus, and familial rheumatoid arthritis.
高纯度、高活性、低内毒素、高批间一致性
Tris-Bis PAGE

Human TNFR2 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
SEC-HPLC

The purity of Human TNFR2 is greater than 90% as determined by SEC-HPLC.
ELISA Data

Immobilized Human TNFR2, His Tag at 0.5 μg/mL (100 μL/Well). Dose response curve for Biotinylated Human TNF alpha, His Tag with the EC50 of 16.6 ng/mL determined by ELISA.
ELISA Data

Immobilized Human TNFR2, His Tag at 0.5 μg/mL (100 μL/Well). Dose response curve for Anti-TNFR2 Antibody, hFc Tag with the EC50 of 12.7 ng/mL determined by ELISA.
-25 ~ -15℃保存,收到货之后有效期1年。
复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1203
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1325
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
748
2026-04-22
【应用方向】TNFR蛋白家族概述
740
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
832
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
661
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
660
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
672
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
605
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19101
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11123
2025-07-09
【技术讲解】重要免疫检查点:PD-1及其配体
20436
2025-07-24
【应用方向】药靶明星|FGFs&FGFRs家族蛋白解析
18702
2025-07-24
【应用方向】热门肿瘤靶点蛋白-EGFR表皮生长因子受体
6532
2025-07-24
【技术讲解】双抗热门靶点-双特异性抗体靶点CD3D&CD3E
14918
2022-09-05





